Centessa Pharmaceuticals PLC ADR
Price & Volume
Stats
See more52W Range | $9.60-$30.58 |
Market Cap | $3.2B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $15M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $15M |
Diluted EPS | -$1.89 |
News
See moreYahoo Finance • 18 days ago
Here are the most and least likely M&A targets in biotech, according to Truist
Yahoo Finance • 2 months ago
Sector Update: Health Care Stocks Higher in Afternoon Trading
Yahoo Finance • 2 months ago
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program
Yahoo Finance • 2 months ago
Warner Bros. Discovery upgraded, F5 downgraded: Wall Street's top analyst calls
About
CEO | Dr. Mario Alberto Accardi Ph.D. |
CFO | Mr. John J. Crowley CPA |
Address | 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 114 |
